| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111356 External preparation for allergic diseases |
| 05/25/2006 | US20060111327 Derivatives of triptolide having a high immunosuppressive effect and high water solubility, and uses thereof |
| 05/25/2006 | US20060111319 Use of dextran sulfate |
| 05/25/2006 | US20060111292 Using gene-regulatory peptide |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110473 Composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 05/25/2006 | US20060110425 Leech extracts for stents |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110372 Regulatory cells that control T cell immunoreactivity |
| 05/25/2006 | US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/24/2006 | EP1659125A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658839A1 Oligonucleotide/carrier combinations targeting CD40 |
| 05/24/2006 | EP1658772A2 Receptor specific transepithelial transport of immunogens |
| 05/24/2006 | EP1658097A1 Nucleotide and cellular vaccine composition |
| 05/24/2006 | EP1658091A1 Pharmaceutical compositions comprising an epitope of platelet gpiiia protein |
| 05/24/2006 | EP1658081A2 Immunosuppressive effects of pteridine derivatives |
| 05/24/2006 | EP1539723B1 Novel use of benzothiazole derivatives |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1465577A4 Methods for improving the aesthetic appearance of skin |
| 05/24/2006 | EP1427428B1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1242102B1 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 05/24/2006 | EP1009419B1 Method for identifying modified recombinant Graminae pollen allergens |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 05/24/2006 | EP0719295B1 Polymeric matrices and their uses in pharmaceutical compositions |
| 05/24/2006 | DE19543271B4 Orales pharmazeutisches Präparat An oral pharmaceutical composition |
| 05/24/2006 | DE102004055998A1 Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie Small-molecule inhibitors of guanine nucleotide exchange factors of the cytohesin family |
| 05/24/2006 | DE102004055891A1 Kit for treating cancer, autoimmune diseases, immune deficiency diseases, and as accompanying therapy for bacterial and viral infections, comprises a mixture of snake toxins from at least three different types of snakes |
| 05/24/2006 | CN1777621A Antibodies against human il-21 receptor and applications therefor |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777580A Prostaglandin derivatives |
| 05/24/2006 | CN1777575A Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 05/24/2006 | CN1777415A Medicinal composition containing edible acid or its acid salt and its use |
| 05/24/2006 | CN1775241A Immunity strengthening agent of traditional Chinese herbs for birds |
| 05/24/2006 | CN1775088A Malt sugar |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1256983C Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 05/24/2006 | CN1256899C Health food with functions of delaying senility and regulating immunity and its preparation process |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049439 Immunomodulators for inducing cytokine biosynthesis; viricides; antitumor agents |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049302 A saponin possessing immune adjuvant activity, derived from Quillaja saponaria; an immunostimulatory oligonucleotide cotaining an unmethylated CpG dinucleotide,wherein the immunostimulatory oligonucleotide is not a part of a DNA vaccine vector |
| 05/23/2006 | US7048933 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048928 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease |
| 05/23/2006 | US7048924 Combination antiviral and interleukin-2 therapy for HIV infection |
| 05/23/2006 | US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/18/2006 | WO2006053166A1 8h-imidazo[4,5-d]thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/18/2006 | WO2006053121A2 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 05/18/2006 | WO2006053120A1 IMIDAZO-FUSED THIAZOLO[4,5-b]PYRIDINE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME |
| 05/18/2006 | WO2006052150A1 Mussel extract composition with enhanced anti-inflammatory activity |
| 05/18/2006 | WO2006052026A1 Acid salt of benzimidazole derivative and crystal thereof |
| 05/18/2006 | WO2006051987A1 Novel drug for inhibiting estrogen-dependent diseases, prostaglandin d (pgd)-dependent gynecological diseases, immunological diseases, cancer and angiogenesis |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051819A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051805A1 MUTANT INTERFERON α PROTEINS AND USE THEREOF |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051390A1 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, pharmaceutical compositions containing them, and methods of preparing them |
| 05/18/2006 | WO2006050949A2 Superagonistic anti-cd28 antibody |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |
| 05/18/2006 | WO2005032484A9 Alkoxy substituted imidazoquinolines |
| 05/18/2006 | US20060106196 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination |
| 05/18/2006 | US20060106111 Phenylnaphthalene compounds |
| 05/18/2006 | US20060106108 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
| 05/18/2006 | US20060106087 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/18/2006 | US20060106069 4-(5-Chloro-2-isopropylaminopyridin-4-yl)-1-(toluene-4-sulfonyl)-1H-pyrrole-2-carboxylic acid methyl ester; mitogen-activated protein kinase inhibitor; antiproliferative, anticarcinogenic agent; study of intracellular signal transduction pathways; evaluation of new kinase inhibitors |
| 05/18/2006 | US20060106052 Method of using sulfonamide substituted imidazoquinolines |